NEORAL for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 22 adverse event reports in the FDA FAERS database where NEORAL was used for Off label use.
Most Reported Side Effects for NEORAL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Blood creatinine increased | 18 | 7.0% | 2 | 7 |
| Death | 17 | 6.6% | 17 | 1 |
| Immunosuppressant drug level increased | 14 | 5.4% | 3 | 7 |
| Renal failure | 13 | 5.0% | 3 | 7 |
| Interstitial lung disease | 11 | 4.3% | 6 | 3 |
| Kidney transplant rejection | 11 | 4.3% | 3 | 7 |
| Renal impairment | 11 | 4.3% | 1 | 3 |
| Maternal exposure during pregnancy | 10 | 3.9% | 0 | 3 |
| Oral administration complication | 9 | 3.5% | 4 | 4 |
| Pyrexia | 9 | 3.5% | 2 | 5 |
| Renal failure acute | 9 | 3.5% | 0 | 8 |
| Drug interaction | 8 | 3.1% | 1 | 6 |
| Dyspnoea | 8 | 3.1% | 4 | 7 |
| Oedema | 8 | 3.1% | 2 | 3 |
| Oedema peripheral | 8 | 3.1% | 1 | 8 |
Other Indications for NEORAL
Renal transplant (52)
Interstitial lung disease (18)
Prophylaxis against transplant rejection (14)
Product used for unknown indication (13)
Immunosuppression (12)
Nephrotic syndrome (10)
Aplastic anaemia (8)
Heart transplant (8)
Liver transplant (8)
Psoriasis (7)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)